Which plant and animal foods are associated with the development of multiple myeloma, and what effect might the spice turmeric have on the progression of monoclonal gammopathy of undetermined significance?
Turmeric Curcumin, MGUS, & Multiple Myeloma
Multiple myeloma is one of the most dreaded cancers; it’s a cancer of our antibody-producing plasma cells, considered one of the most intractable blood diseases for many years. The precursor disease is called monoclonal gammopathy of undetermined significance, or MGUS. When it was named, its significance was undetermined, but now we know that multiple myeloma is almost always preceded by MGUS, which makes it one of the most common premalignant disorders, with a prevalence of about 3% in the older white general population, and about two to three times that in African-American populations.
MGUS itself is asymptomatic; you don’t even know you have it until your doctor finds it incidentally during routine blood work. But should it progress to multiple myeloma, you then have about four years to live. So we need to find ways to treat MGUS early, before it turns into cancer, but no such treatment exists. Rather, patients are just kind of placed in a holding pattern, with frequent checkups. But if all you’re going to do is watch and wait, might as well try out some dietary changes.
The potential role of curcumin, the yellow pigment in the spice turmeric, in patients with MGUS. Why curcumin? Well, it’s relatively safe, considering that it has been consumed as a dietary spice for centuries. And, it kills multiple myeloma cells. Here’s the unimpeded growth of four different cell lines of multiple myeloma. You start out with 5,000 cancer cells at the beginning of the week, which then doubles, triples, quadruples in a matter of days. But if you add a little bit of curcumin or a lot of curcumin, the growth is stunted or stopped. But this is in a Petri dish. Still, exciting enough to justify trying it out in a clinical trial. And six years later, researchers did.
One can measure the progression of the disease by the rise in blood levels of paraprotein, which is what’s made by MGUS and myeloma cells. About 1 in 3 of the patients responded to the curcumin with dropping paraprotein levels, whereas there were no responses in the placebo group. These positive findings prompted them to commence a double-blind, randomized, control trial, and here it is. They saw the same kind of positive biomarker response in both MGUS patients as well as those with so-called smoldering multiple myeloma, an early stage of the disease. These findings suggest that curcumin might have the potential to slow the disease process in patients, delaying or preventing the progression of MGUS to multiple myeloma, but we won’t know until longer larger studies are done.
The best way to deal with multiple myeloma is to not get it in the first place. In 2010 I profiled this study, suggesting that vegetarians have just a quarter the risk of multiple myeloma compared to meat-eaters. Even just working with chicken meat may double one’s risk of multiple myeloma, the thinking being that cancers like leukemias, lymphomas, and myeloma may be induced by viral agents in both cattle and chickens, so-called zoonotic, or animal-to-human-oncogenic, cancer-causing, viruses. Beef, however, was not associated with multiple myeloma.
There are, however, some vegetarian foods we may want to avoid. Harvard reported a controversial link between diet soda and multiple myeloma, implicating aspartame. French fries and potato chips should not be the way we get our vegetables, nor should we probably pickle them. While the intake of shallots, garlic, soy foods, and green tea was significantly associated with a reduced risk of multiple myeloma, intake of pickled vegetables three times a week or more was associated with increased risk.
To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video. This is just an approximation of the audio contributed by Katie Schloer.
Please consider volunteering to help out on the site.
- Indian J Dermatol. 2008;53(2):83-4. A case of multiple myeloma presenting as a bullous dermatosis. Gül U1, Kiliç A, Gönül M, Cakmak SK, Heper AO.
- T Golombick, TH Diamond, V Badmaev, A Manoharan, R Ramakrishna. The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clin Cancer Res. 2009 Sep 15;15(18):5917-22.
- O Landgren, RA Kyle, SV Rajkumar. From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention. Clin Cancer Res. 2011 Mar 15;17(6):1243-52.
- O Landgren, RA Kyle, RM Pfeiffer, JA Katzmann, NE Caporaso, RB Hayes, A Dispenzieri, S Kumar, RJ Clark, D Baris, R Hoover, SV Rajkumar. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009 May 28;113(22):5412-7.
- T Chou. Multiple myeloma : recent progress in diagnosis and treatment. J Clin Exp Hematop. 2012;52(3):149-59.
- AJ Greenberg, CM Vachon, SV Rajkumar. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia. 2012 Apr;26(4):609-14.
- AC Bharti, N Donato, S Singh, BB Aggarwal. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 2003 Feb 1;101(3):1053-62.
- T Golombick, TH Diamond, A Manoharan, R Ramakrishna. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am J Hematol. 2012 May;87(5):455-60.
- TJ Key, PN Appleby, FL Crowe, KE Bradbury, JA Schmidt, RC Travis. Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans. Am J Clin Nutr. 2014 Jul;100 Suppl 1:378S-85S.
- T Moore, P Brennan, N Becker, S de Sanjosé, M Maynadié, L Foretova, P Cocco, A Staines, A Nieters, R Font, A Mannetje, V Benhaim-Luzon, P Boffetta. Occupational exposure to meat and risk of lymphoma: a multicenter case-control study from Europe. Int J Cancer. 2007 Dec 15;121(12):2761-6.
- ES Schernhammer, KA Bertrand, BM Birmann, L Sampson, WC Willett, D Feskanich. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr. 2012 Dec;96(6):1419-28.
- ML Bongers, JG Hogervorst, LJ Schouten, RA Goldbohm, HC Schouten, PA van den Brandt. Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer. PLoS One. 2012;7(6):e38016.
- Q Wang, Y Wang, Z Ji, X Chen, Y Pan, G Gao, H Gu, Y Yang, BC Choi, Y Yan. Risk factors for multiple myeloma: a hospital-based case-control study in Northwest China. Cancer Epidemiol. 2012 Oct;36(5):439-44.
Multiple myeloma is one of the most dreaded cancers; it’s a cancer of our antibody-producing plasma cells, considered one of the most intractable blood diseases for many years. The precursor disease is called monoclonal gammopathy of undetermined significance, or MGUS. When it was named, its significance was undetermined, but now we know that multiple myeloma is almost always preceded by MGUS, which makes it one of the most common premalignant disorders, with a prevalence of about 3% in the older white general population, and about two to three times that in African-American populations.
MGUS itself is asymptomatic; you don’t even know you have it until your doctor finds it incidentally during routine blood work. But should it progress to multiple myeloma, you then have about four years to live. So we need to find ways to treat MGUS early, before it turns into cancer, but no such treatment exists. Rather, patients are just kind of placed in a holding pattern, with frequent checkups. But if all you’re going to do is watch and wait, might as well try out some dietary changes.
The potential role of curcumin, the yellow pigment in the spice turmeric, in patients with MGUS. Why curcumin? Well, it’s relatively safe, considering that it has been consumed as a dietary spice for centuries. And, it kills multiple myeloma cells. Here’s the unimpeded growth of four different cell lines of multiple myeloma. You start out with 5,000 cancer cells at the beginning of the week, which then doubles, triples, quadruples in a matter of days. But if you add a little bit of curcumin or a lot of curcumin, the growth is stunted or stopped. But this is in a Petri dish. Still, exciting enough to justify trying it out in a clinical trial. And six years later, researchers did.
One can measure the progression of the disease by the rise in blood levels of paraprotein, which is what’s made by MGUS and myeloma cells. About 1 in 3 of the patients responded to the curcumin with dropping paraprotein levels, whereas there were no responses in the placebo group. These positive findings prompted them to commence a double-blind, randomized, control trial, and here it is. They saw the same kind of positive biomarker response in both MGUS patients as well as those with so-called smoldering multiple myeloma, an early stage of the disease. These findings suggest that curcumin might have the potential to slow the disease process in patients, delaying or preventing the progression of MGUS to multiple myeloma, but we won’t know until longer larger studies are done.
The best way to deal with multiple myeloma is to not get it in the first place. In 2010 I profiled this study, suggesting that vegetarians have just a quarter the risk of multiple myeloma compared to meat-eaters. Even just working with chicken meat may double one’s risk of multiple myeloma, the thinking being that cancers like leukemias, lymphomas, and myeloma may be induced by viral agents in both cattle and chickens, so-called zoonotic, or animal-to-human-oncogenic, cancer-causing, viruses. Beef, however, was not associated with multiple myeloma.
There are, however, some vegetarian foods we may want to avoid. Harvard reported a controversial link between diet soda and multiple myeloma, implicating aspartame. French fries and potato chips should not be the way we get our vegetables, nor should we probably pickle them. While the intake of shallots, garlic, soy foods, and green tea was significantly associated with a reduced risk of multiple myeloma, intake of pickled vegetables three times a week or more was associated with increased risk.
To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video. This is just an approximation of the audio contributed by Katie Schloer.
Please consider volunteering to help out on the site.
- Indian J Dermatol. 2008;53(2):83-4. A case of multiple myeloma presenting as a bullous dermatosis. Gül U1, Kiliç A, Gönül M, Cakmak SK, Heper AO.
- T Golombick, TH Diamond, V Badmaev, A Manoharan, R Ramakrishna. The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker. Clin Cancer Res. 2009 Sep 15;15(18):5917-22.
- O Landgren, RA Kyle, SV Rajkumar. From myeloma precursor disease to multiple myeloma: new diagnostic concepts and opportunities for early intervention. Clin Cancer Res. 2011 Mar 15;17(6):1243-52.
- O Landgren, RA Kyle, RM Pfeiffer, JA Katzmann, NE Caporaso, RB Hayes, A Dispenzieri, S Kumar, RJ Clark, D Baris, R Hoover, SV Rajkumar. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009 May 28;113(22):5412-7.
- T Chou. Multiple myeloma : recent progress in diagnosis and treatment. J Clin Exp Hematop. 2012;52(3):149-59.
- AJ Greenberg, CM Vachon, SV Rajkumar. Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia. 2012 Apr;26(4):609-14.
- AC Bharti, N Donato, S Singh, BB Aggarwal. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood. 2003 Feb 1;101(3):1053-62.
- T Golombick, TH Diamond, A Manoharan, R Ramakrishna. Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study. Am J Hematol. 2012 May;87(5):455-60.
- TJ Key, PN Appleby, FL Crowe, KE Bradbury, JA Schmidt, RC Travis. Cancer in British vegetarians: updated analyses of 4998 incident cancers in a cohort of 32,491 meat eaters, 8612 fish eaters, 18,298 vegetarians, and 2246 vegans. Am J Clin Nutr. 2014 Jul;100 Suppl 1:378S-85S.
- T Moore, P Brennan, N Becker, S de Sanjosé, M Maynadié, L Foretova, P Cocco, A Staines, A Nieters, R Font, A Mannetje, V Benhaim-Luzon, P Boffetta. Occupational exposure to meat and risk of lymphoma: a multicenter case-control study from Europe. Int J Cancer. 2007 Dec 15;121(12):2761-6.
- ES Schernhammer, KA Bertrand, BM Birmann, L Sampson, WC Willett, D Feskanich. Consumption of artificial sweetener- and sugar-containing soda and risk of lymphoma and leukemia in men and women. Am J Clin Nutr. 2012 Dec;96(6):1419-28.
- ML Bongers, JG Hogervorst, LJ Schouten, RA Goldbohm, HC Schouten, PA van den Brandt. Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer. PLoS One. 2012;7(6):e38016.
- Q Wang, Y Wang, Z Ji, X Chen, Y Pan, G Gao, H Gu, Y Yang, BC Choi, Y Yan. Risk factors for multiple myeloma: a hospital-based case-control study in Northwest China. Cancer Epidemiol. 2012 Oct;36(5):439-44.
Republishing "Turmeric Curcumin, MGUS, & Multiple Myeloma"
You may republish this material online or in print under our Creative Commons licence. You must attribute the article to NutritionFacts.org with a link back to our website in your republication.
If any changes are made to the original text or video, you must indicate, reasonably, what has changed about the article or video.
You may not use our material for commercial purposes.
You may not apply legal terms or technological measures that restrict others from doing anything permitted here.
If you have any questions, please Contact Us
Turmeric Curcumin, MGUS, & Multiple Myeloma
LicenseCreative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Content URLDoctor's Note
For dietary links to other blood cancers, see EPIC Findings on Lymphoma.
The turmeric story just never seems to end. I recommend a quarter teaspoon a day:
- Back to Our Roots: Curry and Cancer
- Carcinogenic Blocking Effects of Turmeric
- Turmeric Curcumin Reprogramming Cancer Cell Death
- Turmeric Curcumin and Colon Cancer
- Topical Application of Turmeric Curcumin for Cancer
Why might garlic and tea help? See Cancer, Interrupted: Garlic & Flavonoids and Cancer Interrupted, Green Tea.
More on the effects of Nutrasweet in Aspartame and the Brain and acrylamide in Cancer Risk From French Fries.
If you haven't yet, you can subscribe to our free newsletter. With your subscription, you'll also get notifications for just-released blogs and videos. Check out our information page about our translated resources.